Wilson Sonsini Goodrich & Rosati is pleased to support LaunchBio’s Larger Than Life Science: Reproductive Revolution, Science & Funding Behind a Groundbreaking Startup. Life science entrepreneurs are looking for informed partners to help them continue to innovate during these uncertain times. BREX, the fintech company that provides corporate credit cards for technology, e-commerce and life science companies has options for venture-backed startups.
BREX employee #1, Larissa Maranhao, interviews Matt Krisiloff, CEO of Ovid Research, in a LaunchBio fireside chat designed for founders, CFOs and COOs. Ovid Research is a Bay area startup with the mission of generating viable human eggs from induced pluripotent stem cells (iPSCs). Successful development of their research could lead to removing age limits on motherhood, allowing for easy screening of eggs with harmful genetic mutations and allowing same-sex couples to reproduce. Learn about their ground-breaking research and how they are leveraging various funding sources to drive their science forward.
Lori Doyle
ldoyle@wsgr.com